Planned Esophagectomy after Neoadjuvant Hyperthermo-Chemoradiotherapy using Weekly Low-Dose Docetaxel and Hyperthermia for Advanced Esophageal Carcinomas.

Masanobu NakajimaHiroyuki KatoMakoto SakaiAkihiko SanoTatsuya MiyazakiMakoto SohdaTakanori InoseNaritaka TanakaShigemasa SuzukiNorihiro MasudaMinoru FukuchiHiroyuki Kuwano

Published in: Hepato-gastroenterology (2016)

Esophagectomy after docetaxel HCRT may have potential for prolonging survival in patients with locally advanced esophageal cancer. A larger randomized, controlled study will be required to confirm the benefit of esophagectomy after HCRT.

Keyphrases

locally advanced
rectal cancer
neoadjuvant chemotherapy
low dose
squamous cell carcinoma
phase ii study
radiation therapy
robot assisted
open label
double blind
high dose
high grade
phase iii
randomized controlled trial
lymph node
risk assessment
free survival